2 Information about cannabidiol

Marketing authorisation indication

2.1 Cannabidiol (Epidyolex, GW Pharma) is indicated 'for use as adjunctive therapy of seizures associated with tuberous sclerosis complex (TSC) for patients 2 years of age and older'.

Dosage in the marketing authorisation

2.2 The dosage schedule is available in the summary of product characteristics for cannabidiol.


2.3 The list price is £850.29 per 100 ml (100 mg/ml) bottle. The company has a commercial arrangement. This makes cannabidiol available to the NHS with a discount. The size of the discount is commercial in confidence. It is the company's responsibility to let relevant NHS organisations know details of the discount.

  • National Institute for Health and Care Excellence (NICE)